Sangsang Tang
Hangzhou, 310006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Proteomic profiling and molecular reclassification of high-grade serous ovarian cancer identifies prognostic subtypes and immunotherapy biomarkers.
Journal: EBioMedicine
Published: May 04, 2025
Performance of multi-parameter differential diagnostic models for ovarian cancer screening in women with adnexal masses.
Journal: Journal of gynecologic oncology
Published: January 05, 2025
Human Papillomavirus Genotype Attribution and Integration in High-Grade Vaginal Intraepithelial Neoplasia.
Journal: Journal of lower genital tract disease
Published: December 02, 2024
Simultaneously delivery of functional gallium ions and hydrogen sulfide to endow potentiated treatment efficacy in chemo- and PARPi-resistant ovarian cancer.
Journal: Journal of nanobiotechnology
Published: November 29, 2024
Combating tumor PARP inhibitor resistance: Combination treatments, nanotechnology, and other potential strategies.
Journal: International journal of pharmaceutics
Published: September 04, 2024
RAD51B-AS1 promotes the malignant biological behavior of ovarian cancer through upregulation of RAD51B.
Journal: Journal of Zhejiang University. Science. B
Published: July 16, 2024
Fatty acid metabolism-related lncRNA prognostic signature for serous ovarian carcinoma.
Journal: Epigenomics
Published: February 15, 2024
Identification of potential novel N6-methyladenosine effector-related lncRNA biomarkers for serous ovarian carcinoma: a machine learning-based exploration in the framework of 3P medicine.
Journal: Frontiers in pharmacology
Published: December 07, 2023
Regulating Cholesterol in Tumorigenesis: A Novel Paradigm for Tumor Nanotherapeutics.
Journal: International journal of nanomedicine
Published: September 12, 2023
PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.
PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 06, 2023
Nanotechnology-integrated ovarian cancer metastasis therapy: Insights from the metastatic mechanisms into administration routes and therapy strategies.
Journal: International journal of pharmaceutics
Published: December 12, 2022
Nanoengineered Gallium Ion Incorporated Formulation for Safe and Efficient Reversal of PARP Inhibition and Platinum Resistance in Ovarian Cancer.
Journal: Research (Washington, D.C.)
Published: December 01, 2022
Last Updated: 09/26/2026